L'vov D K, Samokhvalov E I, Mishiro S, Tsuda F, Selivanov N A, Okamoto H, Stakhanova V M, Gromashevskiĭ V L, Aristova V A, Doroshenko N V, Iashina T L, Kuzin S N, Suetina I A, Lobanov D S, Deriabin P G, Ruzaeva L A, Bezgodov V N, Frizen V I, Firsova L A, Firsova L I, Darizhapov B B, L'vov S D, Smirnov V N, Lisitsina V E, Shchukina I A
Vopr Virusol. 1997 Jul-Aug;42(4):157-61.
The incidence of markers of hepatitis C virus (HCV in the blood of 4216 normal subjects living in the European Russia (Northern, North-Western, Central, Central Chernozem, Volga-Vyatka, Volga, and North Caucasian regions), in the Urals, in Siberia (Eastern Siberian region), in the Far East, and in Monogolia is assessed. The incidence of antibodies to HCV varied from 0.7% in the Central region to 3.8% in the Central Chernozem and 10.7% in Mongolia. HCV genotyping (identification of 1a, 1b, 2a, 2b, and 3a genotypes) was performed using 469 RNA of HCV-positive sera of donors and patients collected in Russia, Moldova, Turkmenistan, and Mongolia. The 1b genotype predominated everywhere (68.9%), its incidence being the highest in Moldova (96%). Unclassifiable variants of HCV were found in 28 (6%) of sera. The regularities of HCV genotypes circulation in the European Russia were the same as in other European countries, whereas their prevalence in Eastern Russia was rather like that in China or Japan. The prevalence of genotypes did not depend on the clinical manifestations of diseases caused by HCV.
